Ms. Denise Faltischek reports
TILRAY INITIATES ROUNDTABLE WITH GERMAN REGULATORS TO KICK-OFF DRAFT LEGISLATION TO LEGALIZE ADULT-USE CANNABIS IN GERMANY
Tilray Brands Inc. has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany. In this meeting, the German Drug Commissioner, Burkhard Blienert, presented the plan for adult-use cannabis legalization and repeated the German government's announcement that a first draft of the bill would be presented in the coming months. With this event, Tilray reaffirms its leading role as a trusted partner to government regulators and contributes to German legalization efforts by sharing its long-standing expertise and experience in cannabis research, product quality and safety, supply management, patient and consumer protection, and cannabis education.
Participants in the meeting included key leaders from Germany's health and legal committees including:
- Burkhard Blienert, Commissioner on narcotic drugs at the Federal Ministry of Health;
- Kristine Lutke, member of the Bundestag (FDP), drug policy spokesperson;
- Carlos Kasper, member of the Bundestag (SPD) Committee on Finance;
- Martina Stamm-Fibich, member of the Bundestag (SPD) Committee on Health.
Denise Faltischek, chief strategy officer and head of international, Tilray Brands, said: "We are honoured to have initiated this high-level exchange on one of the world's most important cannabis endeavours. As a leading global cannabis company, Tilray Brands has unmatched experience partnering with governments and regulators to help develop responsible cannabis regulations that protect the health and safety of patients and consumers, as well as, supporting significant economic growth in countries in which it operates. We applaud the German government in leading responsible adult-use cannabis legislation in Europe and we are proud to support this effort."
Sascha Mielcarek, managing director, Tilray Europe, said: "As a market leader in Germany and Europe, our highest priority for a successful launch of an adult-use market in Germany is to lead with the highest quality-control standards that are consistent and reliable for consumers and patients. Established quality certifications such as European good manufacturing practice (EU-GMP) already enable manufacturers industry-wide to provide patients and consumers with cannabis of the utmost quality and safety. These standards have proven themselves in our everyday medical cannabis practice and can be considered best practices for the recreational market, as they ensure consistent quality products."
Tilray Brands has a pioneering record as a company committed to producing the highest-quality cannabis products available to consumers and patients in need around the world; it was the first to successfully export medical cannabis from North America and import medical cannabis products into the EU (European Union) in 2016. Tilray has made several strategic investments that are now resulting in first-mover advantages in Germany and Europe; the company's operational strength is reflected along the entire value chain with leading medical cannabis brands, a strong distribution network in Germany and end-to-end EU-GMP supply chain, which includes two state-of-the-art EU-GMP production facilities in Portugal and Germany.
About Tilray Brands
Tilray Brands is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is changing people's lives for the better -- one person at a time -- by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul, and invoke a sense of well-being. Tilray's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience of health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and alcoholic beverages.
We seek Safe Harbor.
© 2022 Canjex Publishing Ltd. All rights reserved.